TMSC | Jotup

Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives

Retrieved on:

Thursday, April 18, 2024

Congress, FDA, Woman, Infertility, Health, Research, White, Federation, TMSC, Birth control

Further, Lee-Sepsick is raising awareness of Femasys and the status of its reproductive products in light of the recently announced women’s health initiative from the White House.

Key Points:

Further, Lee-Sepsick is raising awareness of Femasys and the status of its reproductive products in light of the recently announced women’s health initiative from the White House.
“Women’s health remain vastly underserved and underfunded but we are encouraged by the interest our solutions have received during recent meetings with members of Congress,” remarked Lee-Sepsick.
It has four commercially available products: FemaSeed® – FDA-cleared, intratubal insemination, FemVue® – contrast-generating device, FemCath® – selective delivery catheter, and FemCerv® – endocervical tissue sampler.
Although permitted to have multiple FemaSeed attempts, the majority of women who became pregnant did so after the first FemaSeed procedure.

Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility

Retrieved on:

Wednesday, March 20, 2024

Infertility, TMSC, Pregnancy rate, IVF, IUI, Pregnancy, Fertilisation, Woman, Male, Safety, Literature, FDA, ICSI, Insemination, Physician, Birth control

ATLANTA, March 20, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, today announces topline data from its FemaSeed Localized Directional Insemination for artificial insemination pivotal trial (NCT04968847). The trial investigated its FemaSeed product in women with a variety of infertility factors with the primary efficacy analysis focused on the severe male factor infertility. FemaSeed, engineered to enhance fertilization by precisely delivering sperm into the fallopian tube, the site of conception, demonstrated 24% of women became pregnant after FemaSeed with severe male factor (1 million to 20 million total motile sperm count (TMSC)). In contrast, a 6.7% pregnancy rate by cycle was described in the literature for intrauterine insemination (IUI) with male factor (greater than 1 million TMSC).1 Although permitted to have multiple FemaSeed attempts, the majority of women who became pregnant did so after the first FemaSeed procedure. The poor IUI pregnancy rates for this infertility segment usually necessitates assisted reproductive approaches, such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

Key Points:

The trial investigated its FemaSeed product in women with a variety of infertility factors with the primary efficacy analysis focused on the severe male factor infertility.
“These impressive topline results for our now FDA-cleared FemaSeed, demonstrate significant progress in the treatment of infertility, while confirming its safety profile.
“The pivotal trial amassed substantial prospective data in support of the safety and efficacy of FemaSeed as a groundbreaking advancement in artificial insemination.
The pivotal trial was concluded prior to completing full enrollment due to Femasys receiving FDA clearance for FemaSeed under the 510(k) pathway in September 2023.

MediaTek Officially Launches Dimensity 9000 Flagship Chip And Announces Adoption by Global Device Makers

Retrieved on:

Thursday, December 16, 2021

Cortex, GNSS, CTO, Wi-Fi, SIM, IEEE 802.11ax-2021, SOC, Display, PDA Dimensions, AI, MediaTek, Efficiency, APU, HDR, Senior, VAD, G-Mobile, High dynamic range, Noise, IOT, Android, Vulkan (API), Bluetooth, Carrier aggregation, Partnership, Architecture, Vivo, TSMC, TWSE, SDK, Socs, OPPO, General manager, TMSC, Multimedia, Smartphone, Tablet, Arm, CPU, GPU, Industry, 3GPP, Adoption, Goal, Leadership, ISP, Technology, Mobile phone, Video game console, Online shopping, Redmi

HSINCHU, Dec. 16, 2021 /PRNewswire/ -- MediaTek today launched its Dimensity 9000 5G smartphone chip for next-generation flagship smartphones, and announced device maker adoption and endorsements from some of the world's biggest smartphone brands, including OPPO, vivo, Xiaomi and Honor. The first Dimensity 9000 powered flagship smartphones will be in the market in the first quarter of next year.

Key Points:

The first Dimensity 9000 powered flagship smartphones will be in the market in the first quarter of next year.
"The Dimensity 9000 is a milestone for MediaTek, highlighting our rise to incredible with a true flagship 5G smartphone chip.
Dimensity 5G Open Resource Architecture: The Dimensity 9000allows the world's leading smartphone device makers to create customized flagship 5G smartphones that stand out.
In 2022, we look forward to continuing to work closely with MediaTek to launch vivo's first product powered by Dimensity 9000 flagship chip.

MediaTek Officially Launches Dimensity 9000 Flagship Chip And Announces Adoption by Global Device Makers

Retrieved on:

Thursday, December 16, 2021

HSINCHU, Dec. 16, 2021 /PRNewswire/ -- MediaTek today launched its Dimensity 9000 5G smartphone chip for next-generation flagship smartphones, and announced device maker adoption and endorsements from some of the world's biggest smartphone brands, including OPPO, vivo, Xiaomi and Honor. The first Dimensity 9000 powered flagship smartphones will be in the market in the first quarter of next year.

Key Points:

The first Dimensity 9000 powered flagship smartphones will be in the market in the first quarter of next year.
"The Dimensity 9000 is a milestone for MediaTek, highlighting our rise to incredible with a true flagship 5G smartphone chip.
Dimensity 5G Open Resource Architecture: The Dimensity 9000allows the world's leading smartphone device makers to create customized flagship 5G smartphones that stand out.
In 2022, we look forward to continuing to work closely with MediaTek to launch vivo's first product powered by Dimensity 9000 flagship chip.

AGM Group Holdings Inc. Announces First Half 2021 Unaudited Financial Results

Retrieved on:

Wednesday, September 29, 2021

Bitcoin, Bitcoin Cash, RMB, ASIC, Partnership, CSO, Research, Time, N+1, SHI International Corp, NASDAQ, KOI, Advertising, Income, Direct, Financial technology, Depreciation, Miner, Marketing, CEO, TMSC, Company, Defi, Mining, Growth, Knowledge, Samsung, Leadership, Technology, Cryptocurrency, Blockchain, C16, CFO, NFT, Ecosystem, Industry, Animal

BEIJING, Sept. 29, 2021 /PRNewswire/ -- AGM Group Holdings Inc. ("AGMH" or the "Company") (NASDAQ: AGMH ), an integrated technology company focusing on high-performance chip solutions, computing equipment and fintech software services, today announcedits unaudited financial results for the for the six months endedJune 30, 2021.

Key Points:

BEIJING, Sept. 29, 2021 /PRNewswire/ -- AGM Group Holdings Inc. ("AGMH" or the "Company") (NASDAQ: AGMH ), an integrated technology company focusing on high-performance chip solutions, computing equipment and fintech software services, today announcedits unaudited financial results for the for the six months endedJune 30, 2021.
In August 2021, the Company announced the launch of its first ASIC crypto Miner - KOI MINER C16 ("C16").
The decrease of cost of revenue was the result of no revenues in the six months ended June 30, 2021.
ET on Wednesday, September 29, 2021 for the first half ended June 30, 2021 (8:00 p.m.Beijing Time on the same day).

AGM Group Holdings Inc. Announces Entry into ASIC R&D and Manufacturing Field

Retrieved on:

Thursday, August 5, 2021

Bitcoin, Company, Research, U.S. Securities and Exchange Commission, Industry, CSO, TMSC, Securities Act of 1933, Securities Exchange Act of 1934, News, Application-specific integrated circuit, Terminology, Private Securities Litigation Reform Act, Nasdaq, Samsung, Cryptocurrency

The new business segment will be led and operated by the Company's newly hired executives and targeting the institutional market.

Key Points:

The new business segment will be led and operated by the Company's newly hired executives and targeting the institutional market.
As one of the pioneers in the ASIC chip design area, Mr. Chenjun Li has extensive experience in the chip production supply chain.
Mr. Chenjun Li commented, "The Company plans to release the latest ASIC miner and its parameters in the near future.
Incorporated in April 2015 and headquartered in Beijing, China, AGM Group Holdings Inc. is software company, currently providing fintech software, and trading education software and website service.

Generational Equity Advises Baden Feed & Supply in Sale to Turtle Mountain Seed Co.

Retrieved on:

Tuesday, March 16, 2021

Other Professional Services, Pets, Consulting, Specialty, Banking, Professional services, Consumer, Retail, TMSC

Generational Equity , a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of its client, Baden Feed & Supply, LLC to Turtle Mountain Seed Co. Ltd.

Key Points:

Generational Equity , a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of its client, Baden Feed & Supply, LLC to Turtle Mountain Seed Co. Ltd.
Located in Baden, Ontario, Canada, Baden Feed & Supply (Baden) is a manufacturer of wild bird seed, caged bird seed, and pigeon feed, and also sells prepared horse, poultry, dairy, and pet food and supplies.
Formerly Nestibo Agra, Turtle Mountain Seed Co. (TMSC) is located in Deloraine, Manitoba, Canada.
Generational Equity , Generational Capital Markets (member FINRA/SIPC), Generational Wealth Advisors , Generational Consulting Group , and DealForce are part of the Generational Group , which is headquartered in Dallas and is one of the leading M&A advisory firms in North America.